Navigation Links
New Survey Shows Seniors Overwhelmingly Satisfied With Medicare Part D
Date:11/18/2008

e drug coverage just the way it is," said Plasari. "Congress should tread cautiously when it comes to making changes to what arguably has been the most successful large-scale government program in at least a generation."

RetireSafe is a grassroots organization representing more than 400,000 older Americans nationwide. Its mission is to preserve, protect and enhance the option and benefits of seniors and near-seniors. The survey was conducted for RetireSafe by Voter Consumer Research, Inc. of Woodlands, Texas. The data was collected between November 6th and November 13th from a sample of 1000 seniors 65 and older, with a 3.2% margin of error.

For More information visit www.RetireSafe.org


'/>"/>
SOURCE RetireSafe
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Epocrates Survey Identifies Trends in Online Resource Use Among Physicians
2. Consumers Weigh in on Which TV Doc They Would Want as Their Own:Survey Results from the American Board of Medical Specialties Find Dr. House Most Loved/Hated TV Doctor
3. Lumension Uncovers Results of Security Data Protection Survey
4. More Than Half of Consumers Going to Doctors Less Due to Rising Healthcare Costs, According to checkMD Survey : 38 Percent Lack Adequate Employer Healthcare Coverage
5. Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues.
6. New survey: More than half of US chronically ill adults skip needed care due to costs
7. AMN Survey: Nurses to Have Bigger Impact on Hospital Revenue
8. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
9. New Survey Indicates "Highest-Value" Physicians Most Likely to Participate in Aptilons Live Video Detailing Service
10. Ford Motor Co. Tops First-Ever Healthcare Purchasing Power Survey
11. Survey finds widespread dissatisfaction with current health care payment system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... study by researchers from the Medical College of Wisconsin, ... for pain and other sickle cell disease complications in ... both providers and patients were also identified. The ... professor of pediatrics at the Medical College and Children,s ... be presented at the American Society of Hematology meeting ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Sickle cell ... red blood cells, is one of the most ... around the world, including more than 70,000 Americans.(1) ... of the American Society of Hematology highlights intriguing ... pandemic presents for children with this blood disorder, ...
(Date:12/6/2009)... A new study provides welcome news for patients with ... , The condition is estimated to impact 62,000 ... an abnormal clot forms in a vein and restricts ... some cases, the clot may detach from its point ... lungs, causing a potentially fatal condition known as a ...
(Date:12/6/2009)... Volunteer organizations and members of the community, in cooperation with the ... create a holiday party. This year,s attendance is expected to soar ... , ... (PRWEB) December 6, 2009 -- ... Greater VA Healthcare System in West Los Angeles, will once again ...
(Date:12/5/2009)... ORLEANSA new three-drug combination has shown in a phase ... effective regimen" in the treatment of patients newly diagnosed ... in bone marrow, say researchers from Dana-Farber Cancer Institute. ... of the 66 patients treated with the drug combination ... "very good partial response rate" in the phase 2 ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... Englishman’s love for beer and fast food, here’s some live ... on the planet, beating other European counterparts hollow.// ,A ... average life expectancy for English men is 76.6 years, ranked ... leads with an average male life expectancy of 74.8. ...
... of hospital-acquired infections from methicillin-resistant Staphylococcus aureus (MRSA), it ... major hospital trusts // in an attempt to restrict ... NHS Trust is one of the three health care ... Government scheme that would provide tips to combat the ...
... have attained the childbearing age are reported to be unsafe, according ... //In the case of Chicago, it was found to be even ... 49 years age group, at levels which exceeds the federal health ... Jack Darin has termed this as a serious problem. The mercury ...
... not taken to restrict spread of the AIDS pandemic in ... African children would be orphaned // by the end of ... 4 years time. ,The following prediction was projected ... health professionals and Government authorities from Africa, Asia, America and ...
... manufacturer of the experimental AIDS drug GS 9137 Gilead Sciences ... were successful, as lower levels of HIV were noticed in ... The experiment was conducted over a period of 10 days ... were also not seen to be of a serious nature. ...
... The American Association for Homecare announced that it disagreed ... Among them the provision to compel the transfer of ... e year and the suspension of home// health reimbursement ... on their stand, Tom Ryan, Chairman of the American ...
Other Medicine News:Health News:NHS Trust Would Soon Take On The Hospital Superbug 2Health News:The AIDS Pandemic May Orphan 18 Million African Children By 2010 2
(Date:12/4/2009)... N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed ... Food and Drug Administration seeking approval to market its ... patent owned by Takeda Pharmaceutical Company Limited. Watson,s ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
(Date:12/3/2009)... Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company ... for the treatment of immune mediated diseases and cancer, ... conference call on, Tuesday, December 8, 2009 at 11:00am ... to discuss clinical data regarding its HDAC Program (PCI-24781) ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 1The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 3AUDIO from Medialink and Ortho McNeil Janssen Pharmaceuticals Inc 3A Getting Ready for Cold and Flu Season 6416 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 2
... Participating in Bavituximab U.S. Cancer Trial Presents ... to Anti-Angiogenesis Experts -, TUSTIN, Calif., ... PPHM ), a clinical stage biopharmaceutical,company developing ... and,hepatitis C virus infection (HCV), today reported ...
... New data showed that at 48,weeks, significantly ... to non-nucleoside reverse transcriptase inhibitors,(NNRTIs) and protease ... as less than 50 HIV-1 RNA copies/mL) ... (BR) compared with placebo plus a BR.,These ...
Other Medicine Technology:Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 2Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 3Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 2New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 3New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 5New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 6
... density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. ... 10-100 Inaccuracy ... 1.2~2.5 Imprecision(%) ... 1 Dimensions: ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
Research Series 2100 Adjustable-volume Pipette, 10-100 l, single-channel with adjustable-volume setting...
Medicine Products: